The Community Focus Channel is supported with funding from Johnson & Johnson (Gold).
The Non-Malignant Channel is supported with funding from Agios (Gold).
The Thalassemia Channel is supported with funding from Agios (Gold).
VJHemOnc is an independent medical education platform. Supporters, including channel supporters, have no influence over the production of content. The levels of sponsorship listed are reflective of the amount of funding given to support the channel.
ASCAT 2024 | Characterizing distinct mechanisms of heart failure in patients with sickle cell disease
In this interview, Malcolm Walker, MD, FRCP, University College London, London, UK, briefly discusses a publication characterizing left ventricular systolic dysfunction in sickle cell disease (SCD). Prof. Walker highlights that there are several distinct mechanisms by which heart failure can occur in these patients, and it is essential to understand this in order to select the correct preventative strategy and treatment approach. This interview took place at the 19th Annual Scientific Conference of the Academy for Sickle Cell and Thalassaemia (ASCAT 2024) in London, UK.
These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.
